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Acanthifolicin (9,!0-epithio-okadaic acid from Pundoras acunthifolium) inhibited protein phosphatase-1 (PP!) similarly to okadaic acid (IC,, =20 
nM and 19 nM, respectively) but was slightly less active against protein phosphatase-2A (PPZA) (IC,, = 1 nM and 0.2 nM, respectively). Methyl 
esterification of acanthifolicin sharply reduced its activity. PPZA was inhibited with an IC,, = 5.0 FM, whilst PP! was inhibited < 10% at 250 FM 
toxin. Okadaic acid methyl ester was similarly inactive whereas dinophysistoxin-1 (35-methyl okadaic acid) inhibited PPl/2A almost as potently 
as okadaic acid. Pure acanthifolicin/okadaic acid methyl ester may be useful as specific inhibitors of PP2A at l-10 PM concentrations in vitro 
and perhaps in vivo. The data also indicate that a region on these toxins important for PPl/ZA inhibition comprises the single carboxyl group. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Okadaic acid (Fig. 1) is a complex polyether produc- 
ed by marine dinoflagellates that accumulates in marine 
sponges such as Halichondria okadaii and in the 
digestive glands of shellfish [ 1,2]. Its structure is similar 
to acanthifolicin (Fig. l), the first polyether carboxylic 
acid to be reported from marine sources [3]. Okadaic 
acid is a major cause of diarrhetic shellfish poisoning 
(DSP) and a potent non-phorbol ester type tumour pro- 
moter [4,5]. Its effects on smooth muscle contractility 
[6] led Takai et al. [6] to deduce that it was an inhibitor 
of protein phosphatase-1 (PPl) and protein 
phosphatase-2A (PP2A); two of the 4 major protein 
phosphatases in the cytosol of mammalian cells that 
dephosphorylate serine and threonine residues (review- 
ed in [8,9]). These and subsequent studies [lo] 
established okadaic acid as a potent and specific in- 
hibitor of PPl (I& = lo-20 nM) and PP2A (IGO = 
0.1-0.2 nM). In order to begin to delineate in 
molecular terms the nature of protein-ligand interac- 
tions underpinning the inhibition of PPl and PP2A by 
okadaic acid, we investigated the effects of synthetic 
and naturally occurring analogues of this toxin on these 
two enzymes. 
2.1. Sources of marine toxins 
Okadaic acid was obtained from Moana Bioproducts Inc., Har- 
ding Ave., Suite 304, Honolulu, HI, 9681, USA. The methyl ester of 
okadaic acid (methyl okadaate) was prepared and characterized as in 
[l]. Acanthifolicin was isolated from the sponge Pundorus acun- 
thifolium and its methyl ester prepared as in [3]. Proton nuclear 
magnetic resonance data for this ester were: ‘H NMR (CDClp) 
300 MHz (chemical shift (multiplet, J in H,, proton assignments)); 
0.93 (d, 6.75), 0.97 (d, 6.75, H-42), 1.06 (d, 6.75), 1.38 (s, H-44), 1.73 
(s, H-43), 3.25-3.75 (7H, m), 3.80 (s, OCH,), 3.90-4.20 (4H, m), 
4.46 (q, 8, H-16), 5.07 (s, H-4!), 5.38-5.47 (3H, m, H-14, 15, 41); 
exchangeable absorptions at 2.52, 3.01, 5.04. Besides these absorp- 
tions the spectrum contained complex overlapping multiplets in the 
range 1.20-2.35 ppm. The purity of the methyl esters was further 
checked by reverse phase liquid chromatography since these com- 
pounds could be resolved from their non-esterified counterparts. 
Detection by protein phosphatase bioassay indicated that acan- 
thifolicin methyl ester was entirely free of acanthifolicin. Methyl 
okadaate contained 0.02% residual okadaic acid and inhibition data 
(Figs 2 and 3) were corrected to account for this contamination. 
9-Anthryldiazomethyl (ADAM) ester of okadaic acid was a 
generous gift from Dr J. Marr, Oceanchem. Group, Dartmouth, 
Nova Scotia and dinophysistoxin-1 (35-methyl okadaic acid, DTX-1) 
was obtained from Dr M. Quilliam, NRC, Halifax. Monensin and 
nigericin were from Sigma, salinomycin from Calbiochem and 
maduramycin from Dr R. Dickey, United States Food and Drug Ad- 
ministration, Alabama, USA. Brevetoxin B and kabiramide C were 
kindly provided by Dr K. Nakanishi, Columbia University, NY, USA 
and Dr R. Andersen, University of British Columbia, respectively. 
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2.2. Sources of protein preparations 
The biological activity of the marine toxins was assayed by the 
ability of these compounds to inhibit dephosphorylation of “P- 
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Fig. 1. Structures of acanthifolicin, brevetoxin B and kabiramide C. 
Acanthifolicin differs from okadaic acid in having an unusual 
episulphide functionality at the 9-10 carbon position, instead of a 
C=C bond. Dinophysistoxin-I is methylated at the 35-carbon 
position. 
radiolabelled phosphorylase a by protein phosphatases in the stan- 
dard phosphorylase phosphatase assay [ll]. Homogeneous PPl/M 
catalytic subunits were purified from rabbit skeletal muscle [12] and 
generously provided by the United Kingdom Medical Research Coun- 
cil Protein Phosphorylation Group, Dundee (Professor P. Cohen). 
Radiolabelled phosphorylase a was prepared from phosphorylase b
(Boehringer-Mannheim) by phosphorylation with ‘*P-y-ATP (Amer- 
sham) and phosphorylase kinase (Sigma). Prior to use, 
phosphorylase kinase and phosphorylase b preparations were 
routinely preincubated with 25 mM NaF to inhibit endogenous 
phosphatase activity. 
3. RESULTS 
3.1. Effect of acanthifolicin, acanthifolicin methyl 
ester and methyl okadaate on protein phosphatase 
activity 
Acanthifolicin inhibited protein phosphatase-2A 
(PPZA) with slightly less potency than okadaic acid 
(Fig. 2) with an ICSO = 1.0 nM vs 0.2 nM, respectively. 
Full inhibition was achieved at 5.0 nM. Methyl 
esterification of the single carboxyl group on acan- 
thifolicin decreased the potency of inhibition by 
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Fig. 2. Inhibition of protein phosphatase-2A catalytic subunit by 
acanthifolicin (O---• , ACA), acanthifolicin methyl ester (m---m, 
ACAM), okadaic acid (m, OKA) and methyl okadaate (M, 
OKAM). 
NOO-fold, acanthifolicin methyl ester inhibited PP2A 
with an ICSO = 5.0 /IM, complete inactivation occurring 
at 50.0pM. Similar results were achieved with methyl 
okadaate, which inhibited PP2A with an IC~O = 
900 nM. Increasing the size and hydrophobicity of the 
group blocking the carboxyl function of okadaic acid 
had no further effect on activity since the 
9-anthryldiazomethyl (ADAM) ester of okadaic acid 
was almost equally as ineffective as methyl okadaate as 
a PP2A inhiibtor (data not shown). 
Acanthifolicin inhibited protein phosphatase-1 (PPl) 
with similar potency to okadaic acid (Fig. 3), the IGO 
values being 20 and 19 nM, respectively. Full inhibition 
was achieved at 500 nM. Acanthifolicin methyl ester 
had very little effect on PPl activity, even at concentra- 
tions as high as 250 PM. 
3.2. Effect of dinophysistoxin-I and other polyether 
toxins on protein phosphatase activity 
The effect of dinophysistoxin-1 on protein 
phosphatase activity was determined since this com- 
pound is also a potent tumour promoter and is fre- 
quently found in the toxic profile of diarrhetic shellfish 
poisoning [ 131. Dinophysistoxin-1 inhibited PP 1 and 
PPZA with similar potency to okadaic acid, the ICSO 
values being 55 and 0.6 nM, respectively. 
It was also of interest to examine the effects of other 
hydrophobic marine polyether and macrolide toxins on 
protein phosphatase activity. The Cd2 benthic marine 
poison brevetoxin B (Fig. I), from the dinoflagellate 
Ptychodiscus brevis, resembles okadaic acid in size, 
hydrophobicity and structure, being composed of a 
contiguous polyether fused ring structure. The C36 
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Fig. 3. 
These compounds were slightly active against PP2A, 
causing 30 and 20% inhibition, respectively, at 350 PM 
in the phosphorylase a phosphatase assay. 
4. DISCUSSION 
Dinophysistoxin-1 and okadaic acid are powerful 
tumour promoters of comparable potency to phorbol 
esters [5]. Inhibition of PPl/PP2A probably underlies 
acceleration of tumour formation (reviewed in [2]) and 
not surprisingly, the potency of dinophysistoxin-1 as a 
phosphatase inhibitor is consistent with this notion. 
Similarly, acanthifolicin will likely be as powerful a 
tumour promoter as okadaic acid/dinophysistoxin-1 
and by analogy could prove to be a diarrhetic shellfish 
poison [ 131. 
Methyl esterification of the single carboxyl group on 
acanthifolicin (and okadaic acid) drastically reduced 
the potency of these compounds as protein phosphatase 
inhibitors, demonstrating that the region comprising 
this carboxyl group is important for effective inhibition 
of PP1/2A. This finding may facilitate a starting point 
for rational design of smaller synthetic protein 
phosphatase inhibitors. It has been reported that 
okadaic acid tetramethylether (methylated at 2-, 7-, 24- 
and 27-carbon hydroxyl groups) does not promote in- 
tracellular hyperphosphorylation in human fibroblasts 
and is not active as a tumour promoter [14,15]. It is 
presently not known how these methylations contribute 
to loss of biological activity. 
Pure acanthifolicin/okadaic acid methyl esters may 
prove to be effective as specific inhibitors of PP2A at 
l-10 /cM concentrations in vitro and perhaps in vivo. 
In the latter instance, the fluorescent ADAM okadaic 
acid ester may be particularly useful (provided it is not 
rapidly hydrolysed by esterases) since it may facilitate 
in vivo intracellular localization studies. 
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